Please check your internet connection and try again.
# Ferrous Ascorbate
## Overview
Ferrous ascorbate is an iron salt complexed with ascorbic acid. The inclusion of ascorbic acid lowers the gastric pH, which enhances the solubility, bioavailability, and absorption of elemental iron compared to other oral iron formulations.
## Primary Indications
* Treatment of iron deficiency anemia (IDA).
* Prophylaxis of iron deficiency in high-risk populations (e.g., pregnancy, chronic blood loss).
## Adult Dosing
* **Treatment of IDA:** Typical dosage is 100 mg of elemental iron equivalent once or twice daily.
* **Note:** Dosing varies significantly based on local institutional protocols and the severity of anemia (Hb level). Maintenance dosing is often lower (e.g., 50–100 mg daily).
## Pediatric Dosing
* **Prophylaxis:** 1–2 mg/kg/day of elemental iron.
* **Treatment:** 3–6 mg/kg/day of elemental iron, divided into 1–3 doses.
* **Note:** Always verify dosing against the specific salt formulation concentration provided by the manufacturer.
## Dose Adjustments
* **Renal Impairment:** No specific adjustment required, but use with caution in patients with history of iron overload or chronic inflammation.
* **Hepatic Impairment:** Use with caution; monitor for iron overload.
## Contraindications
* Hypersensitivity to iron or ascorbic acid.
* Hemochromatosis, hemosiderosis, or any condition involving iron overload.
* Hemolytic anemia (unless iron deficiency is also present).
* Repeated blood transfusions.
## Adverse Effects
* **Gastrointestinal:** Epigastric pain, nausea, constipation, diarrhea, and dark-colored stools (expected).
* **Systemic:** Teeth staining (liquid formulations), metallic taste.
* **Overdose:** Potentially fatal in children; symptoms include abdominal pain, vomiting, bloody diarrhea, shock, and metabolic acidosis.
## Key Drug Interactions
* **Antacids/H2-Blockers/PPIs:** Decrease iron absorption; separate by at least 2 hours.
* **Fluoroquinolones/Tetracyclines:** Iron chelates with these antibiotics, significantly reducing their absorption; separate by 2–4 hours.
* **Levodopa/Methyldopa:** Absorption may be reduced by iron salts.
* **Calcium supplements:** Can inhibit iron absorption if taken concurrently.
## Monitoring
* **Efficacy:** Reticulocyte count (7–10 days post-initiation), Hemoglobin/Hematocrit (4 weeks post-initiation), and Ferritin (3 months post-initiation).
* **Safety:** Monitor for GI intolerance and signs of systemic iron overload in chronic therapy.
## Clinical Pearls
* **Bioavailability:** Best absorbed on an empty stomach. If GI side effects are limiting, administer with food, though this may decrease overall absorption.
* **Ascorbic Acid Synergism:** The presence of ascorbic acid maintains iron in the ferrous (Fe2+) state, facilitating better absorption in the duodenum.
* **Toxicity:** Always store out of reach of children. Even small amounts can be toxic to toddlers.
***
**Educational Disclaimer:** This information is for educational purposes only. Clinical protocols for iron replacement therapy vary locally; always verify specific dosing, safety profiles, and regional guidelines against the latest prescribing information or institutional clinical decision support tools before administration.
